EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biomimetic Metal–Organic Framework Gated Nanoplatform for Sonodynamic Therapy against Extensively Drug Resistant Bacterial Lung Infection

Jianling Huang, Xiuwen Hong, Sixi Chen, Yucong He, Lixu Xie, Fenglin Gao, Chenghua Zhu, Xiao Jin, Haihao Yan, Yongxia Ye, Mingyue Shao, Xingran Du iD und 1 weitere

Advanced Science · 2024-09 · 11 (33)

DOI: 10.1002/advs.202402473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 04.07.2024. Verfasst von Jianling Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210011, China. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Anti-Bacterial Agents. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, The Medical-Industrial Integration Project of the Second Affiliated Hospital of Nanjing Medical University, Beijing Medical and Health Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Novel antimicrobial strategies are urgently needed to treat extensively drug‐resistant (XDR) bacterial infections due to the high mortality rate and lack of effective therapeutic agents. Herein, nanoengineered human umbilical cord mesenchymal stem cells (hUC‐MSCs), named PMZMU, are designed as a sonosensitizer for synergistic sonodynamic‐nano‐antimicrobial therapy against gram‐negative XDR bacteria. PMZMU is composed of a bacterial targeting peptide (UBI 29‐41 ) modified hUC‐MSCs membrane (MSCm), a sonosensitizer meso‐tetra(4‐car‐boxyphenyl) porphine doped mesoporous organo‐silica nanoparticle and an acidity‐responsive metal–organic framework ZIF‐8. This innovative formulation enables efficient loading of polymyxin B, reduces off‐target drug release, increases circulation and targeting efficacy, and generates reactive oxygen species upon ultrasound irradiation. PMZMU exhibits remarkable in vitro inhibitory activity against four XDR bacteria: Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa (PA), and Escherichia coli . Taking advantage of the bacterial targeting ability of UBI 29‐41 and the inflammatory chemotaxis of hUC‐MSC, PMZMU can be precisely delivered to lung infection sites thereby augmenting polymyxin B concentration. PMZMU‐mediated sonodynamic therapy significantly reduces bacterial burden, relieves inflammatory damage by promoting the polarization of macrophages toward M 2 phenotype, and improves survival rates without introducing adverse events. Overall, this study offers promising strategies for treating deep‐tissue XDR bacterial infections, and guides the design and optimization of biomimetic nanomedicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metal-Organic FrameworksAnti-Bacterial AgentsAnimalsHumansDisease Models, AnimalNanoparticlesMiceUltrasonic TherapyBiomimeticsDrug Resistance, Multiple, BacterialMesenchymal Stem CellsBiomimetic MaterialsPseudomonas aeruginosa

Stichwörter der Autor:innen

biomimetic nanoplatformextensively drug resistant bacteriamesenchymal stem cellsmetal–organic frameworkpolymyxin Bsonodynamic therapy

Substanzen

Metal-Organic FrameworksAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210011, China.
  • Department of Pulmonary and Critical Care Medicine, Qi Lu Hospital of Shandong University, Wen hua xi Road 107#, Jinan, 250012, China.
  • Department of Radiology, Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, 210009, China.
  • Department of Respiratory and Critical Care Medicine, The Affiliated Jiangning Hospital with Nanjing Medical University, Nanjing, 211100, China.

ORCID-Profile: Xingran Du, Ganzhu Feng

Förderung

  • National Natural Science Foundation of China
  • The Medical-Industrial Integration Project of the Second Affiliated Hospital of Nanjing Medical University
  • Beijing Medical and Health Foundation

Zitieren

APA

Huang, J., Hong, X., Chen, S., He, Y., Xie, L., Gao, F., Zhu, C., Jin, X., Yan, H., Ye, Y., Shao, M., Du, X., & Feng, G. (2024). Biomimetic Metal–Organic Framework Gated Nanoplatform for Sonodynamic Therapy against Extensively Drug Resistant Bacterial Lung Infection. Advanced Science, 11(33). https://doi.org/10.1002/advs.202402473

Vancouver

Huang J, Hong X, Chen S, He Y, Xie L, Gao F, et al. Biomimetic Metal–Organic Framework Gated Nanoplatform for Sonodynamic Therapy against Extensively Drug Resistant Bacterial Lung Infection. Advanced Science. 2024;11(33). doi:10.1002/advs.202402473

BibTeX
@article{Huang2024,
  author = {Huang, Jianling and Hong, Xiuwen and Chen, Sixi and He, Yucong and Xie, Lixu and Gao, Fenglin and Zhu, Chenghua and Jin, Xiao and Yan, Haihao and Ye, Yongxia and Shao, Mingyue and Du, Xingran and Feng, Ganzhu},
  title = {Biomimetic Metal–Organic Framework Gated Nanoplatform for Sonodynamic Therapy against Extensively Drug Resistant Bacterial Lung Infection},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {33},
  doi = {10.1002/advs.202402473}
}
Kostenlos starten →